H-89

H-89 is an inhibitor of PKA used in studies of GPCR Signaling. It is especially relevant in cancer and cell signaling models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

By inhibiting PKA, H-89 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving PKA
• Pathway perturbation studies connected to GPCR Signaling
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, H-89 is appropriate when a defined chemical perturbant is needed to connect PKA with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.